Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19

Background: In November 2020, the FDA issued an emergency use authorization (EUA) for monoclonal antibodies (mAbs) to be used in outpatients with COVID-19 infections who are at a high risk of progressing to severe disease. However, becuase the EUA had limited indications for inpatients, data on thei...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Adam Zimilover (Yazar), Thien-Ly Doan (Yazar), Sumeet Jain (Yazar), Prashant Malhotra (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Cambridge University Press, 2022-07-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Connect to this object online.

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede